Ipsen
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ipsen
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.
/ 
Frequently asked questions
To buy Ipsen stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ipsen by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ipsen is IPN:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ipsen has its primary listing on Euronext Paris. You can trade Ipsen with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ipsen is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Ipsen as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Ipsen.